Gender disparities in cancer outcomes are evident. For instance, men generally have poorer survival rates for most cancers compared to women. This can be attributed to later-stage diagnoses, differences in tumor biology, and lifestyle factors such as higher rates of smoking and alcohol consumption among men. Women, however, may face gender biases in clinical trials and healthcare access, potentially affecting their treatment outcomes.
